联系方式:400-990-3999 / 邮箱:sales@xiyashiji.com
西亚试剂 —— 品质可靠,值得信赖
Patient-Specific Pluripotent Stem Cells Become Even More Accessible
Shinya Yamanaka
1 Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan
2 Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA
In this issue of Cell Stem Cell, Staerk et al. (2010), Seki et al. (2010),Staerk et al. (2010), Seki et al. (2010), and Loh et al. (2010) each describe the derivation of human iPSCs from peripheral blood. Although seemingly incremental, this advance brings the stem cell field an important step closer to eventual clinical use.
生物谷推荐Tomohisa Seki等发表文章的索引
Cell Stem Cell doi:10.1016/j.stem.2010.06.003
Generation of Induced Pluripotent Stem Cells from Human Terminally Differentiated Circulating T Cells
Tomohisa Seki1, 7, Shinsuke Yuasa1, 2, 7, Mayumi Oda2, Toru Egashira1, Kojiro Yae1, Dai Kusumoto1, Hikari Nakata1, Shugo Tohyama1, Hisayuki Hashimoto1, Masaki Kodaira1, Yohei Okada2, 3, Hiroyuki Seimiya4, Noemi Fusaki5, 6, Mamoru Hasegawa5 and Keiichi Fukuda1
1 Department of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan
2 Center for Integrated Medical Research, Keio University School of Medicine, Tokyo 160-8582, Japan
3 Department of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan
4 Division of Molecular Biotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan
5 DNAVEC Corporation, Ibaraki 1-25-11, Japan
6 PRESTO, JST, Saitama 332-0012, Japan